The Treatment of Chronic Type B Viral Hepatitis (1988)

Editorials15 July 1988The Treatment of Chronic Type B Viral HepatitisRichard D. Aach, MDRichard D. Aach, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-109-2-89 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptViral hepatitis B remains a major problem in public health. The Centers For Disease Control (CDC) estimates that there are more than 300 000 new cases of acute hepatitis B per year in the United States alone (1). There are an estimated 1 million chronic carriers of hepatitis B virus (HBV) in this country and more than 200 million carriers worldwide. The CDC also estimates that each year in the United States there are 4000 deaths due to cirrhosis and 1000 deaths from hepatocellular carcinoma (hepatoma) among persons with chronic HBV infection. In countries where HBV is endemic,...References1. Immunization Practices Advisory Committee. Update on hepatitis B prevention. MMWR. 1987;36:353-60, 366. MedlineGoogle Scholar2. SeeffKoff LR. Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis. 1986;6:11-22. CrossrefMedlineGoogle Scholar3. ChuKarayiannisFowlerMonjardinoLiawThomas CPMJYH. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology. 1985;5:431-4. CrossrefMedlineGoogle Scholar4. BrechotDegosLugassy CFC. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. New Engl J Med. 1985;302:270-6. CrossrefGoogle Scholar5. PopperShafritzHoofnagle HDJ. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology. 1987;7:764-72. CrossrefMedlineGoogle Scholar6. MondelliEddleston MA. Mechanism of liver cell injury in acute and chronic hepatitis B. Semin Liver Dis. 1984;4:47-58. CrossrefMedlineGoogle Scholar7. Dienstag J. Immunologic mechanisms in chronic viral hepatitis. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. New York: Grune and Stratton; 1984:135-66. Google Scholar8. ThomasLeverScullyPignatelli HAMM Approaches to the treatment of hepatitis B virus and delta-related liver disease. Semin Liver Dis. 1986;6:34-41. CrossrefMedlineGoogle Scholar9. GarciaSmithWeissberg GCJ. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B: a randomized, double-blinded, placebo-controlled trial. Ann Intern Med. 1987;107:278-85. LinkGoogle Scholar10. Burke C. A statistical view of clinical trials in chronic hepatitis B. J Hepatol. 1986;3(Suppl 2):S261-7. CrossrefMedlineGoogle Scholar11. SamplinerHamiltonIseriTaborBoitnott RFOEJ. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci. 1979;277:17-22. CrossrefMedlineGoogle Scholar12. HoofnagleDusheikoSeeffJonesWaggonerBaks JGLEJZ. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med. 1981;94:744-88. LinkGoogle Scholar13. SagnelliPiccininoManzillo EFG. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBcAg and antiHBe. Hepatology. 1983;3:690-5. CrossrefMedlineGoogle Scholar14. NahTongStevensonRoskampBoone PMDDC. Effects of short-term high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. Liver. 1985;5:8-12. MedlineGoogle Scholar15. SchalmHeytinkvan Buurende Man SRHR. Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B. Lancet. 1985;2:358-60. CrossrefMedlineGoogle Scholar16. DavisHoofnagle GJ. Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology. 1986;6:1038-41. CrossrefMedlineGoogle Scholar17. Eddleston A. Interferons in the treatment of chronic hepatitis B virus infection. Med Clin North Am. 1986; May suppl: 25-30. CrossrefMedlineGoogle Scholar18. AlexanderBrahmFagan GJE. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet. 1987;1:66-9. CrossrefMedlineGoogle Scholar19. OmataUchiumi MK. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B: a long-term follow-up study. Hepatology. 1986;3:(Suppl 2):S65-9. CrossrefGoogle Scholar20. PerrilloRegensteinPeters RFM. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis: a randomized, controlled trial. Ann Intern Med. 1988;109:95-100. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Sinai Hospital of Baltimore The Johns Hopkins University, School of Medicine Baltimore, Maryland Nextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByProfessionalism revisited during the pandemics of our time: COVID-19 and racismHepatitis virus infectionsNucleic Acid-Based Cross-Linking Assay for Detection and Quantification of Hepatitis B Virus DNARobustaflavone, a potential non-nucleoside anti-hepatitis B agentHepatitis B: diagnosis, prevention, and treatmentThe value of quantitative measurement of HBeAg and HBsAg before interferon-α treatment of chronic hepatitis B in childrenThymosin: An Innovative Approach to the Treatment of Chronic Hepatitis BTherapies for Hepatitis B Virus: Current Status and Future PossibilitiesLack of association between schistosomiasis and hepatitis B virus infection in Gezira-Managil area, SudanRecombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trialInterferon and Delta HepatitisBruno Taillan, MD, Jean-Gabriel Fuzibet, MD, Henri Vinti, MD, Alain Pesce, MD, Jill-Patrice Cassuto, MD, Pierre Dujardin, MD 15 July 1988Volume 109, Issue 2Page: 89-91KeywordsAcute hepatitis BCirrhosisHepatitis AHepatitis BHepatitis B virusHepatocellular carcinomaPrevention, policy, and public health Issue Published: 15 July 1988 PDF DownloadLoading ...